Trials / Completed
CompletedNCT00438776
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Lindner Center of HOPE · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olanzapine | 2.5mg to 15mg daily |
| DRUG | sugar pill | matching placebo to olanzapine |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2007-02-22
- Last updated
- 2011-12-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00438776. Inclusion in this directory is not an endorsement.